Tag:
companion diagnostic
Latest Headlines
Latest Headlines
Ventana to work with Seattle Genetics, Millennium on companion Dx
The companion diagnostic trend continues--and Ventana Medical Systems is involved yet again. This morning, Seattle Genetics and Takeda's Millennium unit announced that they are working with the Roche company on a companion diagnostic test for use in a study involving Adcetris.
Genoptix test to guide melanoma treatment decisions
Personalized medicine has been a popular topic in medical device and biopharma circles as of late. One company that has long had its eye on this area is Genoptix Medical Laboratory.
Everist launches companion Dx, prognostics portfolio for colorectal cancer
Colorectal cancer is a growing disease burden in the U.S., with roughly 140,000 new cases being diagnosed each year, according to the National Cancer Institute . Ann Arbor, MI-based Everist Genomics, which we profiled in our 5 innovative Michigan companies report last year, is looking to combat the disease and allow doctors to find it early enough to help patients.
Abbott, Merck keep companion Dx trend going with cancer test
We've been hearing a lot about companion diagnostics lately--especially as to how they can help save the healthcare system money by identifying those patients who might respond to certain treatments.
Siemens teams up with ViiV, Tocagen on companion Dx
Siemens ( $SI ) is taking a big step into the hot companion diagnostic arena. The company, which makes a wide range of products, has announced separate pacts with ViiV Healthcare and Tocagen related to
Quest's companion diagnostic confronts Tysabri brain infection risk
It's a vexing problem that certain drugs with enormous benefit can also carry significant health risk. Case in point: Some patients who take the multiple sclerosis drug Tysabri experience improved
Ventana, Bayer to collaborate on companion Dx for cancer
Another week, another big personalized medicine partnership announcement from Ventana Medical Systems . This time, the Roche unit said it will be working with Bayer Pharma on a molecular companion
Ventana, Pfizer, CST collaborate on NSCLC companion diagnostic
In its latest of a series of companion diagnostic announcements, Roche's Ventana unit says it is collaborating with Pfizer ( $PFE ) and Cell Signaling Technology (CST) to develop a test identifying
Ventana inks separate companion Dx deals
Waltham, MA-based Syndax Pharmaceuticals is teaming up with Roche's Ventana Medical Systems to develop a companion diagnostic assay to select those non-small cell lung cancer patients who could
PwC report predicts companion diagnostic surge, more M&A in IVD market
An uptick in companion diagnostics partnerships will increase investor interest in the global IVD market over the next couple of years, according to a new PwC report. The report also predicts a surge
